Skip to main content

Helix Biopharma Corp(HBP-T)
TSX

Today's Change
Real-Time Last Update

Helix Biopharma Corp

40 Temperance Street
Suite 2700, Bay Adelaide Centre - North Tower
Toronto ON M5H0B4 CAN
P: 857-208-7687
https://www.helixbiopharma.com

Sectors & Indices

Sector
Industry
Employees

Profile

Helix BioPharma Corp is a clinical-stage biopharmaceutical company developing therapies in immune-oncology focused on cancer prevention and treatment. The Company is developing a proprietary platform of bio-conjugates targeting hard-to-treat solid tumors over-expressing CEACAM6, including Tumor Defense Breaker, L-DOS47, and three CEACAM6-specific antibody-drug conjugates. Its pre-IND candidates include LEUMUNA, an oral immune checkpoint modulator for hematological malignancies, and GEMCEDA, an oral prodrug of gemcitabine for solid tumors.

Key Executives

NameTitle
Jacek AntasChairman of the Board/Director/Secretary
Rohit BabbarCFO
Thomas MehrlingCEO/Chief Medical Officer
Veronika KandzioraCOO
Davide GuggiChief Technology Officer

More from The Globe

Insider Report: Chair sells $5-million from this stock yielding 5.8% that’s doubled in under a year
The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022. THE CANADIAN PRESS/Nathan Denette
Canaccord reworks U.S. leadership in wake of regulatory settlement
The logo for Canaccord Genuity is shown in Toronto on Wednesday, March 8, 2023. THE CANADIAN PRESS/Staff
Bullish on FirstEnergy Corp.
Monica Rizk
The most oversold and overbought stocks on the TSX
The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022.
Monday’s analyst upgrades and downgrades
A Dollarama store is seen Tuesday, June 11, 2013 in Montreal. Dollarama Inc. raised its quarterly dividend by 10 per cent as it reported its fourth-quarter profit and sales rose compared with a year ago. THE CANADIAN PRESS/Paul Chiasson
opinion
Why are Canadian bank valuations so low?
Tom Bradley
number cruncher
Eleven U.S. semiconductor stocks showing strength
For Number Cruncher column in Globe Investor/ROB only.
Wednesday’s analyst upgrades and downgrades
An office building for Goeasy Ltd, a personal lender for subprime borrowers, in Mississauga, Ontario, on March 10, 2026.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.